Scoop has an Ethical Paywall
Turia "Stunned" By Herceptin Decision
Turia "Stunned" By Herceptin Decision
Tariana Turia admits she is stunned by the decision by PHARMAC and DHBNZ not to fund the drug Herceptin for women with early breast cancer.
“There was sufficient evidence that showed women in the early stages of the disease who used Herceptin at the diagnosis of breast cancer experienced positive effects” said Mrs Turia, Maori Party Co-leader and Health spokesperson.
“This will a huge impact on women and appears to me, to be just another excuse to deny women access to new treatment” said Mrs Turia.
Breast cancer is the most common cancer among women in Aotearoa. Māori women have a 47.7% higher death rate from breast cancer than non-Māori women. Maori women with breast cancer also have poorer survival rates than non-Maori.
Ends
Gordon Campbell: On unemployment, Winston Peters’ low boiling point and music criticism
Labour Party: National Gaslights Women Fighting For Equal Pay
The Treasury: New Treasury Paper On The Productivity Slowdown
NZ Government: Government Recommits To Equal Pay
Emily Ireland - Local Democracy Reporter: Deputy Mayor ‘disgusted’ By Response To Georgina Beyer Sculpture
Te Pāti Māori: Māori Unemployment Rate Increases By More Than Four-Times National Rates
Government: Streamlining Building Consent Changes
